Endomimetics

About Endomimetics

Endomimetics™ is dedicated to transforming patient care by enhancing the safety and performance of surgical and implantable medical devices through their proprietary Bionanomatrix™ technology. Their mission is to develop healing solutions that reduce complications, minimize repeat procedures, and improve the functionality of medical implants.

Products & Services

Bionanomatrix™ Technology:A peptide-based coating or gel designed for medical applications, improving tissue integration, accelerating healing, extending implant lifespan, and reducing adverse reactions. It is customizable for various devices including cardiovascular, orthopedic, and surgical implants, with benefits like high biocompatibility, superior performance, and minimal complications.

Bionanomatrix™ AVF Gel Formulation:Designed to improve the maturation of arteriovenous fistulas (AVFs) for dialysis by enhancing vasodilation, promoting healthy healing, and limiting neointimal hyperplasia.

Bionanomatrix™ Coating for Knee Implants:Infuses knee implants with nitric oxide and antibiotics to prevent infections and reduce scarring that impairs function and movement.

Bionanomatrix™ for Dental Implants:Developed in partnership with BISCO, Inc., to create materials for direct pulp capping and enhance dental device integration to combat peri-implantitis.

Bionanomatrix™ Coating for Brain Aneurysms:A coating for flow diverters and occluders to accelerate healing, reduce blood clot risks, and decrease reliance on blood-thinning medications in brain aneurysm treatment.

Specialties

Bioengineering Bionanomatrix™ Technology Medical Implants Cardiovascular Health Dialysis and Vascular Access Orthopedics Dental Implants Brain Aneurysm Treatment

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Phase I SBIR Grant T: - FT: Phase I SBIR Grant	A: 300000 MR: - FA: $300 thousand FAN: 300000	D: 2024-10-10 FD: 2024-10-10	1 investors
2	RT: Phase II SBIR Grant T: - FT: Phase II SBIR Grant	A: 2800000 MR: - FA: $2.8 million FAN: 2800000	D: 2024-09-17 FD: 2024-09-17	1 investors
3	RT: Grant T: - FT: Grant	A: 100000 MR: - FA: 100,000 FAN: 100000	D: 2024-07-09 FD: 2024-07-09	2 investors
4	RT: SBIR Grant T: - FT: SBIR Grant	A: 292000 MR: - FA: $292 thousand FAN: 292000	D: 2023-11-07 FD: 2023-11-07	1 investors

Phase I SBIR Grant Latest

2024-10-10

$300K

1 investor (Pro only)

Phase II SBIR Grant 2024-09-17

$2.8M

Grant 2024-07-09

$100K

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Joseph N. Garner

Chief Executive Officer

B

Brigitta C. Brott

Chief Medical Officer & Co-Founder

H

Ho-Wook Jun

Biomedical Engineering Faculty

J

Jennifer Sherwood

Director, Research & Development

R

Reid C. Millican

Director, Business Development

J

Jun Chen

Senior Scientist

View 5 more team members with Pro

Unlock Full Team Directory

Recent News

Endomimetics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised